Old news but interesting for someone trying to get up to speed :-)
SARASOTA, Fla.--(BUSINESS WIRE)--Aug. 10, 2000--DNAPrint genomics, Inc., (Pink Sheets:DNAP), a Sarasota, Florida based genomics company, announced today that Chief Scientific Officer, Dr. Tony Frudakis, was featured on CEOcast.com, the premier source of original and syndicated streaming broadcast interviews of Chief Executive Officers at news-making public and private companies.
The live audio interview can be accessed on the Internet at ceocast.com.
Referring to the potential of the genomics industry, Dr. Frudakis says, ``Due to the power of the human genome project and the tools that have come from it, population-wide and systematic studies of genotype-phenotype relationships are possible for the first time in human history.''
Dr. Frudakis explains, ``We believe that our informatics platform will constitute the operating system for personalized medicine in the future. The potential for diagnomics products could easily exceed that for traditional protein-based or immunological-based diagnostic products. First and foremost, diagnomics products will help to prevent disease (by avoiding suboptimal patient-drug combinations) not just report disease after it happens. Secondly, diagnomics products have a greater market (especially as baby boomers age). Virtually every person who uses (prescription medication) is a potential customer.''
About CEOcast
Organized by industry, its analysts average more than 15 years' experience covering and evaluating Wall Street's leading companies. CEOcast's programming is distributed to millions of online investors at more than 700 financial Web sites as well as to more than 20,000 portfolio managers, buy-side analysts and traders at more than 3,300 North American institutions. Content is also disseminated to more than 7,000 investment research professionals representing more then 425 institutions. All content is copyrighted to protect the company's licensing partners.
About DNAPrint genomics
DNAPrint genomics, Inc. provides practitioners of genomic research and personalized medicine with a comprehensive system for complex trait dissection and patient classification. DNAPrint genomics Inc. was founded by a group of scientists with research and commercial experience in high-level mathematical modeling, programming and molecular genetics. For more information about the company, please visit www.dnaprint.com.
Except for factual statements made herein, the information contained in this press release consists of forward-looking statements that involve risks and uncertainties. The Company's actual results could differ materially from those contained in such statements. Factors that could cause or contribute to such differences include unexpected shortages of critical components, rescheduling or cancellation of customer orders, the timing and market acceptance of new product introductions by the Company and its competitors, and general competition and price pressures in the marketplace.
--------------------------------------------------------------------------------
Contact:
For scientific inquiries:
DNAPrint genomics, Inc., Sarasota
Dr. Tony Frudakis, 941/351-4543
or |
